Status:

COMPLETED

Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Astellas Pharma US, Inc.

Conditions:

Febrile Neutropenia

Eligibility:

All Genders

18+ years

Brief Summary

Invasive fungal infections are an important cause of morbidity and mortality in patients with neutropenia who are receiving chemotherapy for cancer. Early diagnosis of these infections is difficult an...

Detailed Description

Objectives This retrospective cohort analysis of converting from caspofungin to micafungin as empiric antifungal therapy for cancer patients who are persistently febrile and neutropenic after receivi...

Eligibility Criteria

Inclusion

  • All patients admitted to BWH/DFCI who received at least 2 doses of caspofungin with an Absolute Neutrophil Count (ANC) \< 500, for persistent febrile neutropenia from 11/1/2005 - 10/31/2006, as there first antifungal agent.
  • All patients admitted to BWH/DFCI who received at least 2 doses of micafungin with an Absolute Neutrophil Count (ANC) \< 500 for persistent febrile neutropenia from 11/1/2006 - 10/31/2007 as there first antifungal agent

Exclusion

  • Patients receiving an echinocandin antifungal agent (micafungin or caspofungin) for an indication other then empiric therapy in febrile neutropenia
  • Patients receiving therapy for an active or on-going invasive fungal infection
  • Patients who received both caspofungin and micafungin during the same admission
  • Patients with an ANC \> 500 at when either micafungin or caspofungin was started
  • Patients who received another antifungal agent for persistent febrile neutropenia, e.g., voriconazole, amphotericin B liposome, posaconazole, etc... Before they received an echinocandin (caspofungin or micafungin) will be excluded

Key Trial Info

Start Date :

January 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2008

Estimated Enrollment :

323 Patients enrolled

Trial Details

Trial ID

NCT00723073

Start Date

January 1 2008

End Date

May 1 2008

Last Update

August 31 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115